END TERM PROJECT

Being market leader it has best chances but high input costs are putting pressure on margins plus rising interest costs are going against the stock. It has taken a sharp run in the last rally and now there is a dip in the volumes in the past. 11)RANBAXY PHARMACEUTICALS: Should be bought. ................
................